Apolipoprotein A1 (ApoA1) is the primary protein associated with high-density lipoprotein (HDL) particles, and plays a central role in reverse cholesterol transport.
HDL cholesterol (HDL-C) and ApoA1 concentrations are inversely related to the risk for coronary artery disease (CAD).
There are a variable number of ApoA1 proteins per HDL particle. Therefore, ApoA1 is not a 1:1 surrogate marker for HDL particles.
Similarly, the number of ApoA1 proteins and the amount of cholesterol contained in HDL particles is highly variable. This heterogeneity has led to unique clinical findings related to ApoA1 compared with HDL-C.
Reference ranges:
Males:
|
Age |
Apolipoprotein A (mg/dL) |
|
<24 months |
Not established |
|
2-17 years |
Low: <115 Borderline low: 115-120 Acceptable: >120 |
|
>18 years |
> or =120 |
Females:
|
Age |
Apolipoprotein A (mg/dL) |
|
<24 months |
Not established |
|
2-17 years |
Low: <115 Borderline low: 115-120 Acceptable: >120 |
|
>18 years |
> or =140 |
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.